Barclays Maintains an 'Overweight' on Cardinal Health (CAH); 'Up or No?' Expectations Into Q4
Tweet Send to a Friend
Barclays maintains an 'Overweight' on Cardinal Health (NYSE: CAH), price target $40.
Barclays analyst says, "In anticipation of Cardinal's Q4 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Barclays analyst says, "In anticipation of Cardinal's Q4 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
